Jennifer graduated in 2009 from the University of Bath with a First Class MChem honours degree in Chemistry for Drug Discovery with Industrial Training. She then completed a PhD in Organic Chemistry at the University of Bath, focusing on the asymmetric synthesis of highly substituted lactones for use in natural product synthesis. She joined HGF in May 2016.
Jennifer’s undergraduate degree provided her with a broad understanding of medicinal chemistry, including some aspects of biochemistry and pharmacology. She completed an industrial placement at AstraZeneca where she worked as a Synthetic Organic Chemist in the lead optimisation stage of drug discovery. Her PhD research involved the development of novel methodology for the asymmetric synthesis of building blocks for use in natural product synthesis. This work resulted in three publications and was presented at two international conferences.
After her PhD, Jennifer spent two years working in R&D for a specialist diabetes diagnostics company. This project focused on the design and synthesis of novel boronic acid fluorophore conjugates for use in an HbA1c assay.
Before joining HGF, Jennifer was the Industry Manager for the NIHR Diagnostic Evidence Cooperative based at Imperial College London. During this time, she was responsible for developing a portfolio of industry collaborative clinical studies for Point-of-Care in vitro diagnostic device evaluation.
Chemistry for Drug Discovery
Organic Synthetic Chemistry
Jennifer organised a firm-wide tutorial series for trainee patent attorneys who took the UK qualifying exams in 2018 and 2019. She also regularly attends IP Inclusive events.
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …Event details
The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …Read article
Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that communications are deemed to …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …Event details
Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …Event details
The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.